CURE’s childhood cancers page is a go-to resource for oncology news and updates in the world of childhood cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in childhood cancers.
May 29th 2024
Retevmo was approved for childhood metastatic medullary thyroid, thyroid and solid tumors with RET mutations or gene fusions.
Genomics Data Could Lead to New Treatments for Children
March 12th 2019St. Jude Children’s Research Hospital is offering cloud-based access to the fully sequenced genomes of 10,000 pediatric patients with cancer, in the hopes that sharing the information will lead to the highest possible number of treatment breakthroughs.
Radiation Treatment May Impair Recent Memory in Pediatric Patients With Brain Tumors
September 24th 2018“Key brain regions that we know are typically involved in autobiographical memory formation and retrieval, especially the hippocampus, are located quite far from the primary tumor bed, and thus far from the site of focal radiation,” Sekeres, who is director of the Sekeres Memory Laboratory at Baylor University, said in an interview with CURE.
FDA Approves Tasigna for Pediatric CML
March 22nd 2018Tasigna (nilotinib) was granted Food and Drug Administration (FDA) approval, to be used in the first- and second-line setting for pediatric patients 1 year old or older who have Philadelphia chromosome–positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP).
Childhood Pneumonia May Be Associated With Cancer Risk
February 2nd 2018While causes for pneumonia were varied – including bacteria (14 percent), virus (22 percent) and unspecified (64 percent) – the majority of children did not have immune deficiencies recorded at the time of their pneumonia diagnosis.
We Can. I Can. How One Innovator Is Working to Bring HOPE to Pediatric Patients With Cancer
February 2nd 2018The children’s app is paired with a complementary parent and caregiver-focused platform and guide that helps drive conversations about disease and treatment, timed to the child’s progression and in language that aligns with the game.